P3 Health Partners Inc.
PIII
$10.03
-$0.28-2.72%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Revenue | 0.60% | -2.28% | -4.21% | -3.81% | 2.45% |
| Total Other Revenue | 131.37% | 99.68% | 124.73% | -- | -- |
| Total Revenue | 2.81% | -0.87% | -2.76% | -2.15% | 4.20% |
| Cost of Revenue | -6.73% | -4.27% | -2.57% | -0.88% | 10.14% |
| Gross Profit | 195.76% | 82.89% | -2.11% | -45.42% | -944.38% |
| SG&A Expenses | 2.42% | -8.30% | -10.74% | 1.67% | 0.34% |
| Depreciation & Amortization | -0.96% | -1.62% | -2.20% | -2.56% | -1.88% |
| Other Operating Expenses | -57.60% | -54.09% | -65.08% | -89.84% | 336.79% |
| Total Operating Expenses | -7.10% | -5.67% | -4.94% | -1.45% | 12.79% |
| Operating Income | 52.94% | 28.46% | 15.21% | -2.70% | -82.31% |
| Income Before Tax | 27.97% | 5.23% | -4.92% | -11.79% | -75.71% |
| Income Tax Expenses | -344.51% | -396.49% | -53.84% | 566.97% | -15.67% |
| Earnings from Continuing Operations | 32.33% | 9.58% | -4.09% | -14.45% | -73.13% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -32.13% | -10.65% | 0.35% | 5.30% | 50.86% |
| Net Income | 32.56% | 8.27% | -8.91% | -27.61% | -110.10% |
| EBIT | 52.94% | 28.46% | 15.21% | -2.70% | -82.31% |
| EBITDA | 72.07% | 38.55% | 20.02% | -5.56% | -166.43% |
| EPS Basic | 36.67% | 23.20% | 12.69% | -25.62% | -78.59% |
| Normalized Basic EPS | 34.11% | 15.49% | 13.47% | -337.56% | -912.17% |
| EPS Diluted | 2.15% | -5.53% | -13.76% | 15.88% | -11.90% |
| Normalized Diluted EPS | 27.66% | 8.50% | -8.82% | -350.03% | -1,094.37% |
| Average Basic Shares Outstanding | 9.11% | 13.34% | 22.44% | 13.82% | 24.71% |
| Average Diluted Shares Outstanding | 110.06% | 117.23% | 87.29% | 12.28% | -11.68% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |